Royalty Pharma (RPRX) announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Sun will be based in Hong Kong and lead the company’s royalty business in Asia.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RPRX:
- Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
- Royalty Pharma price target raised to $50 from $45 at TD Cowen
- The Week That Was, The Week Ahead: Macro and Markets, Feb. 15
- Royalty Pharma Earnings Call Balances Strength And Risk
- Royalty Pharma price target raised to $51 from $45 at Goldman Sachs